Molecules/DINUTUXIMAB BETA

DINUTUXIMAB BETA

Molecular Identity

AntibodyApprovedFirst approved 2017

Mechanism of action: Disialoganglioside GD2 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

DINUTUXIMAB BETAQARZIBA (PREVIOUSLY DINUTUXIMAB BETA EUSA AND DINUTUXIMAB BETA APEIRON)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to DINUTUXIMAB BETA

Loading drug network...